CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.
CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.
复制标题
DOI:
10.1073/pnas.1814052115
复制
发表时间:
2018-12-11
影响因子:
11.1
通讯作者:
Chiang EY
中科院分区:
文献类型:
--
作者:
Du X;de Almeida P;Manieri N;de Almeida Nagata D;Wu TD;Harden Bowles K;Arumugam V;Schartner J;Cubas R;Mittman S;Javinal V;Anderson KR;Warming S;Grogan JL;Chiang EY
CD226 is an important activating receptor involved in mediating natural killer (NK) cell responses against tumors, but how CD226 exerts control over NK cell function is not fully understood. CD226 belongs to the poliovirus receptor (PVR)-nectin family that includes TIGIT and CD96, with TIGIT garnering much attention as a key checkpoint in T cell and NK cell antitumor responses and as an immunotherapy target. Thus, it is imperative to determine how CD226 counteracts the actions of TIGIT and CD96 with which it competes for binding to its ligands such as CD155 (PVR). We demonstrate that CD226 engagement of CD155 is required for phosphorylation of transcription factor FOXO1, resulting in inactivation of its negative regulatory control over NK cell effector function. Natural killer (NK) cell recognition of tumor cells is mediated through activating receptors such as CD226, with suppression of effector functions often controlled by negative regulatory transcription factors such as FOXO1. Here we show that CD226 regulation of NK cell cytotoxicity is facilitated through inactivation of FOXO1. Gene-expression analysis of NK cells isolated from syngeneic tumors grown in wild-type or CD226-deficient mice revealed dysregulated expression of FOXO1-regulated genes in the absence of CD226. In vitro cytotoxicity and stimulation assays demonstrated that CD226 is required for optimal killing of tumor target cells, with engagement of its ligand CD155 resulting in phosphorylation of FOXO1. CD226 deficiency or anti-CD226 antibody blockade impaired cytotoxicity with concomitant compromised inactivation of FOXO1. Furthermore, inhibitors of FOXO1 phosphorylation abrogated CD226-mediated signaling and effector responses. These results define a pathway by which CD226 exerts control of NK cell responses against tumors.
登录
查看更多内容
影响因子:
48
作者:
Anderson KR;Haeussler M;Watanabe C;Janakiraman V;Lund J;Modrusan Z;Stinson J;Bei Q;Buechler A;Yu C;Thamminana SR;Tam L;Sowick MA;Alcantar T;O'Neil N;Li J;Ta L;Lima L;Roose-Girma M;Rairdan X;Durinck S;Warming S
通讯作者:
Warming S
影响因子:
4.8
作者:
Kwon, Hyung-Joon;Kwon, Soon Jae;Kim, Hun Sik
通讯作者:
Kim, Hun Sik
影响因子:
32.4
作者:
Kim MV;Ouyang W;Liao W;Zhang MQ;Li MO
通讯作者:
Li MO
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
50.3
作者:
Johnston, Robert J.;Comps-Agrar, Laetitia;Grogan, Jane L.
通讯作者:
Grogan, Jane L.